Skip to main content
. Author manuscript; available in PMC: 2016 Jan 27.
Published in final edited form as: AIDS. 2015 Jan 28;29(3):361–371. doi: 10.1097/QAD.0000000000000543

Table 2.

Number of individuals with incomplete adherence by the different adherence measures and standardized cut-off points among adults in selected antiretroviral treatment programs in Tanzania, Uganda and Zambia, 2011.

Complete population
Sample from sites with
VL measurements
Cut-off n/N a % less than the cut-off n/N b %
Self-reported adherence measures
 % ARV drugs missed – last 3 days 100% 249/4299 5.8 109/1470 7.4
95% 249/4299 5.8 109/1470 7.4
90% 235/4299 5.5 106/1470 7.2
80% 130/4299 3.0 55/1470 3.7
 % ARV drugs missed – last 30 days 100% 517/4289 12.1 239/1460 16.4
95% 113/4289 2.6 43/1460 2.9
90% 46/4289 1.1 14/1460 1.0
80% 22/4289 0.5 8/1460 0.5
 % ARV drugs missed – visual analogue
 scale, last 30 days
100% 2599/4450 58.4 682/1484 46.0
95% 1730/4450 38.9 427/1484 28.8
90% 1119/4450 25.1 253/1484 17.0
80% 511/4450 11.5 85/1484 5.7
 Case Adherence Index >10 751/4473 16.8 304/1493 20.4
 Missed ≥48 consecutive hours of
  ARV drugs in last 3 months
Yes 141/4425 3.2 64/1471 4.4
Other adherence measures
 Healthcare provider report 100% 3150/4415 71.3 792/1463 54.1
95% 1835/4415 41.6 476/1463 32.5
90% 1236/4415 28.0 302/1463 20.6
80% 594/4415 13.5 157/1463 10.7
 Pharmacy medication possession
  ratio (MPR)
100% 3261/4070 80.1 1275/1450 87.9
95% 2131/4070 52.4 837/1450 57.7
90% 1634/4070 40.1 659/1450 45.4
80% 979/4070 24.1 429/1450 29.6
a

Number nonadherent/total number of individuals with data in the population. ARV, antiretroviral.

b

The denominators for these adherence measures vary due to missing data mainly on the current ART regimen and associated daily pill burden needed to calculate adherence.